Brief: Citius Pharmaceuticals Announces Filing Of Form S-3 Shelf Registration Statement To Replace Expiring Prior Shelf Registration
26/02/2024 12:40
Feb 26 (Reuters) - Citius Pharmaceuticals Inc CTXR.O :
* CITIUS PHARMACEUTICALS ANNOUNCES FILING OF FORM S-3 SHELF
REGISTRATION STATEMENT TO REPLACE EXPIRING PRIOR SHELF
REGISTRATION
Source text for Eikon: ID:nPn2FLhx6a
Further company coverage: CTXR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Pharmaceuticals
See all newsCitius Pharmaceuticals Q2 revenue rises on LYMPHIR launch
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules